Chip Somodevilla/Getty Images News The four astronauts aboard Artemis II crossed into the moon’s gravitational influence early Monday, marking a key moment in their journey as they prepare to pass over the lunar far side and set a new record for human spaceflight distance. Traveling in NASA’s Orion spacecraft after last week’s launch from Florida, the crew is scheduled to wake Monday morning for t...
Chip Somodevilla/Getty Images News The four astronauts aboard Artemis II crossed into the moon’s gravitational influence early Monday, marking a key moment in their journey as they prepare to pass over the lunar far side and set a new record for human spaceflight distance. Traveling in NASA’s Orion spacecraft after last week’s launch from Florida, the crew is scheduled to wake Monday morning for the sixth day of their mission. By the evening, they are expected to reach approximately 252,757 miles (406,772.96 kilometers) from Earth, surpassing the long-standing distance milestone set by the Apollo 13 astronauts more than five decades ago. NASA astronauts Reid Wiseman , Victor Glover and Christina Koch , along with Canadian astronaut Jeremy Hansen will circle the moon’s far side at an altitude of roughly 4,000 miles (6,437.38 kilometers). From that vantage point, they will observe the moon’s shadowed terrain with Earth appearing as a small, distant sphere in the background. This flyby represents a pivotal phase of the nearly 10-day mission, the first crewed test flight in NASA’s broader Artemis program. The initiative aims to return humans to the lunar surface later this decade and establish a sustained presence there, laying groundwork for eventual missions to Mars and positioning the U.S. in a renewed space race with China. Beginning in the afternoon, the spacecraft’s trajectory will carry it behind the moon, temporarily cutting off communications as the lunar body blocks signals from NASA’s global tracking network. The blackout period, caused by the obstruction of the NASA Deep Space Network , is expected to last several hours. During the flyby, the astronauts will document the journey with high-resolution imagery captured through Orion’s windows. Their observations will include sunlight bending around the moon’s edge, producing eclipse-like visuals that offer both striking imagery and scientific insight. As the spacecraft emerges from behind the moon, the crew is ...
Getty Images Immunity Bio ( IBRX ) will employ extended promotional review protocols, executive training, and external regulatory oversight as part of a plan to address US FDA concerns over marketing materials related to its bladder cancer treatment Anktiva (nogapendekin alfa). The company also told the FDA that a television advertisement never aired. In March, the agency issued Immunity Bio a war...
Getty Images Immunity Bio ( IBRX ) will employ extended promotional review protocols, executive training, and external regulatory oversight as part of a plan to address US FDA concerns over marketing materials related to its bladder cancer treatment Anktiva (nogapendekin alfa). The company also told the FDA that a television advertisement never aired. In March, the agency issued Immunity Bio a warning letter over a TV advertisement and a podcast that it alleged spread false and misleading information. That led to a significant drop in shares that day. The company has now removed the podcast from its corporate website and has requested third-party platforms do the same. Immunity Bio told the FDA that the podcast, featuring founder and Executive Chairman Patrick Soon-Shiong, was "intended to convey [his] aspirational and forward-looking opinions regarding his vision for the company’s drug development pipeline and the underlying science supporting the strategy of treating patients with cancer," according to a news release . More on ImmunityBio ImmunityBio: No Need To Rush Into Buying Today - Why I'm Downgrading To Hold ImmunityBio's Anktiva Could See More Upside: My Updated Thoughts On Expansion ImmunityBio, Inc. (IBRX) Q4 2025 Earnings Call Transcript ImmunityBio secures $75M financing under Oberland deal ImmunityBio falls as FDA issues warning over Anktiva ad, podcast
Investing.com -- Analysts at Citigroup are heading into the first-quarter semiconductor earnings season with a cautious overall outlook, but have added upside catalyst watches on two names, AMD and Analog Devices.
Investing.com -- Analysts at Citigroup are heading into the first-quarter semiconductor earnings season with a cautious overall outlook, but have added upside catalyst watches on two names, AMD and Analog Devices.
(RTTNews) - The Canadian market may open with a slightly positive bias Monday morning amid reports the U.S. and Iran are engaged in indirect negotiations to explore a potential 45-day truce that could lead to a more permanent resolution to the conflict.
(RTTNews) - The Canadian market may open with a slightly positive bias Monday morning amid reports the U.S. and Iran are engaged in indirect negotiations to explore a potential 45-day truce that could lead to a more permanent resolution to the conflict.
"We Must Be Clear-Eyed": Harris Calls To Oppose New SCOTUS Nominees "Before They Happen" Authored by Jonathan Turley, Former Vice President Kamala Harris is rallying Democratic donors to oppose “additional justices” that might be nominated by President Donald Trump “before they happen.” Harris is heralding the fundraising by Josh Orton, president of the dark- money group “Demand Justice” ( made in...
"We Must Be Clear-Eyed": Harris Calls To Oppose New SCOTUS Nominees "Before They Happen" Authored by Jonathan Turley, Former Vice President Kamala Harris is rallying Democratic donors to oppose “additional justices” that might be nominated by President Donald Trump “before they happen.” Harris is heralding the fundraising by Josh Orton, president of the dark- money group “Demand Justice” ( made infamous for its campaign to get Justice Stephen Breyer to resign). Demand Justice has pushed a radical agenda, including court packing . In a post on X, Harris highlighted a New York Times article on the “liberal organization” “preparing a multimillion–dollar effort to oppose potential Trump Supreme Court appointees before they happen.” Orton announced that “the project would cost $3 million to start and $15 million more if vacancies occurred.” The group expressly cited the possibility of Justices Clarence Thomas (77) and Samuel Alito (76) retiring. Harris called upon people to contribute, posting that : “We must be clear eyed about what is at stake with the Supreme Court right now. We cannot allow Donald Trump to hand pick one, if not two, additional justices. The nation’s highest court must be stopped from becoming even more beholden to him.” We must be clear eyed about what is at stake with the Supreme Court right now. We cannot allow Donald Trump to hand pick one, if not two, additional justices. The nation's highest court must be stopped from becoming even more beholden to him. https://t.co/RF8GJYwptz — Kamala Harris (@KamalaHarris) April 3, 2026 Harris reportedly supports court packing and could use radical groups like Demand Justice to push through an expansion of the Court to produce an immediate liberal majority if Democrats take power. Harris is right about one thing. This is an clear-eyed, remorseless strategy on the left to remove an obstacle to an equally radical agenda. Years ago , Harvard professor Michael Klarman laid out a radical agenda to change the system...
CrowdStrike Holdings ( CRWD ) on Monday announced the repurchase of up to an additional $500 million of Class A common stock to its existing stock repurchase program, bringing the total authorization under the program to $1.5 billion. Under its existing share repurchase program, CrowdStrike has repurchased 413,130 shares of its outstanding Class A common stock at an average price of $364.57 per sh...
CrowdStrike Holdings ( CRWD ) on Monday announced the repurchase of up to an additional $500 million of Class A common stock to its existing stock repurchase program, bringing the total authorization under the program to $1.5 billion. Under its existing share repurchase program, CrowdStrike has repurchased 413,130 shares of its outstanding Class A common stock at an average price of $364.57 per share, for an aggregate purchase price of $150.6M. "We have increased our share repurchase authorization to $1.5 billion to opportunistically return value to shareholders as we progress toward our goal of reaching $20 billion in ending ARR by FY36," said CrowdStrike’s CFO Burt Podbere . Source: Press Release More on CrowdStrike CrowdStrike: Make Sure You Capitalize On The Market Misunderstanding CrowdStrike And The AI Agents Cyber Threat CrowdStrike: Unjustified SaaS Fears (Rating Upgrade) CrowdStrike rises as Benchmark starts with Buy rating Identity, network and endpoint security stand least at risk to LLM disruption: Jefferies
Dan Ives of Wedbush Securities has been one of the loudest voices calling defense AI a generational spending cycle, and his latest comments make the investment thesis more concrete. Asked about the fiscal 2026 OMB budget proposal and its increased AI spending allocations, Ives named names. It’s going to be massive. I mean, look, it ... Wedbush’s Ives: Palantir, Oracle, Microsoft to dominate defens...
Dan Ives of Wedbush Securities has been one of the loudest voices calling defense AI a generational spending cycle, and his latest comments make the investment thesis more concrete. Asked about the fiscal 2026 OMB budget proposal and its increased AI spending allocations, Ives named names. It’s going to be massive. I mean, look, it ... Wedbush’s Ives: Palantir, Oracle, Microsoft to dominate defense AI integration
Welcome to the Mideast Money newsletter , where we chronicle the intersection of money and power in a region that’s become one of the most influential in global finance. This week , let’s dive straight into the latest on the US-Israeli war on Iran. Markets are on edge over whether a breakthrough can be reached ahead of President Donald Trump’s latest deadline to Tehran. Axios reported that Pakista...
Welcome to the Mideast Money newsletter , where we chronicle the intersection of money and power in a region that’s become one of the most influential in global finance. This week , let’s dive straight into the latest on the US-Israeli war on Iran. Markets are on edge over whether a breakthrough can be reached ahead of President Donald Trump’s latest deadline to Tehran. Axios reported that Pakistan, Egypt and Turkey are pushing to secure a potential ceasefire — lasting about 45 days — to head off threatened US strikes on Iran’s energy infrastructure and retaliation by the Islamic Republic against countries in the region. Fighting continued, with Israel, Kuwait and the United Arab Emirates reporting Iranian attacks overnight into Monday. Israel struck Iran’s biggest petrochemical facility, which is responsible for 50% of the petrochemical production in the country. Also Read : Here’s a List of Gulf Energy Infrastructure Damaged in Iran War Trump on Sunday issued an expletive-laced threat to destroy Iran’s power plants and blow up “everything over there,” before announcing what appeared to be a new 8 p.m. Tuesday deadline, without offering details. The move adds to a series of extensions since he began issuing similar ultimatums on March 21 to force Iran to reopen the Strait of Hormuz. Meanwhile, traffic through the strategic waterway has climbed to its highest levels since the early days of the war. The strait saw 21 ships transit over the weekend as more energy-starved governments negotiate to extract vessels, cargoes and crews from the Persian Gulf, strengthening Tehran’s grip on the waterway. Also Read : Saudis Raise Asia Oil to Record Premium as War Upends Market Still, oil prices remained elevated. Brent crude is trading around $109 a barrel — up about 50% since the conflict began — while US gasoline prices have crossed the politically sensitive $4-per-gallon threshold for the first time since 2022, increasing pressure on the Trump administration. Related Covera...
National Healthcare Properties ( HLTC ) on Monday said in a preliminary prospectus filed with the SEC that it is offering class A shares in an initial public offering. The shares are expected to be listed on the Nasdaq Global Select Market under the ticker symbol NHP. Net proceeds are expected to be used to repay outstanding debt under HLTC's revolving credit facility, to fund external growth, and...
National Healthcare Properties ( HLTC ) on Monday said in a preliminary prospectus filed with the SEC that it is offering class A shares in an initial public offering. The shares are expected to be listed on the Nasdaq Global Select Market under the ticker symbol NHP. Net proceeds are expected to be used to repay outstanding debt under HLTC's revolving credit facility, to fund external growth, and for other general corporate purposes. The number of shares to be sold and the price range for the proposed offering are yet to be disclosed. More on National Healthcare Properties, Inc. National Healthcare Properties, Inc. 2025 Q4 - Results - Earnings Call Presentation National Healthcare Properties, Inc. (HLTC) Q4 2025 Earnings Call Prepared Remarks Transcript National Healthcare Properties announces draft registration statement for public stock offering Financial information for National Healthcare Properties, Inc.
The transaction includes intellectual property , customer-related assets and commercial operations, positioning the Company for the next stage of its strategy
The transaction includes intellectual property , customer-related assets and commercial operations, positioning the Company for the next stage of its strategy
Residential buildings in Nanjing, Jiangsu, on April 1, 2026. Photo: VCG For more than two decades, China’s real estate industry operated on a simple, perilous premise: high debt, high leverage, and rapid turnover. As long as property values climbed, underlying operational risks were masked. Today, that era is definitively over. As China begins implementing the recently released proposals for its 1...
Residential buildings in Nanjing, Jiangsu, on April 1, 2026. Photo: VCG For more than two decades, China’s real estate industry operated on a simple, perilous premise: high debt, high leverage, and rapid turnover. As long as property values climbed, underlying operational risks were masked. Today, that era is definitively over. As China begins implementing the recently released proposals for its 15th Five-Year Plan (2026-2030), the focus has shifted entirely to de-risking the sector and engineering a fundamentally new development model.
(RTTNews) - Apnimed, Inc., a pharmaceutical company, Monday announced that it has obtained a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners, a subsidy of investment firm KKR & Co. Inc.
(RTTNews) - Apnimed, Inc., a pharmaceutical company, Monday announced that it has obtained a senior secured credit facility for up to $150 million with funds managed by HealthCare Royalty Partners, a subsidy of investment firm KKR & Co. Inc.